TegoScience Inc. (KOSDAQ:191420)

Market Cap	96.08B -23.3%
Revenue (ttm)	5.94B -12.1%
Net Income	-7.01B
EPS	-876.00
Shares Out	8.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,481
Average Volume	16,068
Open	11,910
Previous Close	12,000
Day's Range	11,180 - 11,910
52-Week Range	11,090 - 20,250
Beta	0.69
RSI	38.36
Earnings Date	n/a

About TegoScience

TegoScience Inc., a biotechnology-based cosmetics company, engages in the production of various skin cell therapy products originating from human epithelial cells in South Korea. The company offers Holoderm, a commercialized cultured skin autograft; Kaloderm, an allogeneic cell therapy product for healing wounds; Rosmir, a fibroblast cell therapy; and Neoderm, a three-dimensionally cultured skin model. It also provides KCM for skin regeneration effect; Chemotide, a single-chain human peptide; contract research services, such as biologics qualit...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2001
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 191420